Aktif Tedavi Planları

67

12%

Başarı Oranı

94.2%

3.1%

İlaç Etkileşimleri

8

5%

Reçete Edilen İlaçlar

324

8.5%

Örnek Tedavi Planı

Patient: P-1023 | Diagnosis: Community-Acquired Pneumonia (J18.9)

İlaç Tedavisi

  • Amoxicillin-Clavulanate 875mg/125mg

    PO BID x 7 days | Priority: STAT

    High Priority
  • Azithromycin 500mg

    PO daily x 5 days | Priority: Routine

    Routine
  • Acetaminophen 500mg

    PO Q6H PRN fever/pain | Max 3g/day

    PRN
İlaç Etkileşimi Uyarısı

No significant interactions detected for current medication regimen.

İlaç Dışı Müdahaleler

  • Oxygen Therapy

    Maintain SpO2 >92% via nasal cannula 2-4L/min

  • Respiratory Physiotherapy

    Incentive spirometry Q2H while awake

  • Hydration

    Encourage PO fluids 2-3L/day or IV NS at 100mL/hr

İzleme Planı

  • Vital signs Q4H (BP, HR, RR, Temp, SpO2)
  • Daily chest auscultation for crackles/wheezing
  • CBC, CMP on Day 3 to assess response
  • Chest X-ray follow-up in 48-72 hours
  • Monitor for adverse drug reactions (rash, GI upset)

Tedavi Hedefleri

  • Resolution of fever within 48-72 hours
  • Improvement in respiratory symptoms (cough, dyspnea)
  • SpO2 >95% on room air by Day 5
  • Clear chest X-ray by Week 2-3
  • Return to baseline functional status

Son Tedavi Planları

Hasta ID Tanı İlaçlar Durum Tarih İşlemler
P-1023 Pneumonia (J18.9) Amoxicillin-Clav, Azithromycin Active 2024-01-15 14:30
P-0987 STEMI (I21.9) Aspirin, Clopidogrel, Atorvastatin Critical 2024-01-15 13:15
P-0892 Ischemic Stroke (I63.9) Alteplase, Aspirin Active 2024-01-15 12:00